We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.43%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.1B
AUM Growth
+$6.94B
(+18%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$231M |
| 2 |
Amgen
AMGN
|
+$171M |
| 3 |
Johnson & Johnson
JNJ
|
+$158M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$153M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$209M |
| 2 |
Broadcom
AVGO
|
+$207M |
| 3 |
TJX Companies
TJX
|
+$195M |
| 4 |
Emerson Electric
EMR
|
+$193M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.07% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Trip.com Group
TCOM
$26.7B
| $1.47M | ﹤0.01% |
40,937
-1,362
| -3% | -$46.4K |
|
802
SPDR Gold Trust
GLD
$130B
| $1.47M | ﹤0.01% |
7,700
| – | – |
|
803
Tarsus Pharmaceuticals
TARS
$2.61B
| $1.46M | ﹤0.01% |
+72,032
| New | +$1.2M |
|
804
InMode
INMD
$889M
| $1.43M | ﹤0.01% |
64,351
-7,778
| -11% | -$175K |
|
805
Perrigo
PRGO
$1.48B
| $1.42M | ﹤0.01% |
+44,174
| New | +$1.32M |
|
806
Jabil
JBL
$31.5B
| $1.42M | ﹤0.01% |
11,145
+9,508
| +581% | +$1.21M |
|
807
American Airlines Group
AAL
$9.91B
| $1.42M | ﹤0.01% |
103,180
+27,794
| +37% | +$349K |
|
808
Invesco
IVZ
$13.1B
| $1.41M | ﹤0.01% |
79,056
-497,184
| -86% | -$7.17M |
|
|
SAGE
809
DELISTED
Sage Therapeutics
SAGE
| $1.4M | ﹤0.01% |
+64,801
| New | +$1.28M |
|
810
EQT Corp
EQT
$31B
| $1.37M | ﹤0.01% |
35,366
-10,723
| -23% | -$435K |
|
|
DHC
811
Diversified Healthcare Trust
DHC
$2.22B
| $1.34M | ﹤0.01% |
+357,720
| New | +$841K |
|
812
First Industrial Realty Trust
FR
$9.13B
| $1.33M | ﹤0.01% |
25,345
-2,480
| -9% | -$116K |
|
813
Chart Industries
GTLS
| $1.33M | ﹤0.01% |
9,756
-771
| -7% | -$104K |
|
814
Dycom Industries
DY
$12.2B
| $1.31M | ﹤0.01% |
11,400
-3,600
| -24% | -$342K |
|
815
Qfin Holdings
QFIN
$1.55B
| $1.3M | ﹤0.01% |
82,083
-4,767
| -5% | -$73K |
|
|
GTHX
816
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.29M | ﹤0.01% |
+423,869
| New | +$796K |
|
817
Kornit Digital
KRNT
$696M
| $1.29M | ﹤0.01% |
67,363
-10,928
| -14% | -$189K |
|
818
Pyxis Oncology
PYXS
$150M
| $1.27M | ﹤0.01% |
+708,303
| New | +$1.21M |
|
819
Performance Food Group
PFGC
$17.6B
| $1.24M | ﹤0.01% |
17,884
-13,505
| -43% | -$830K |
|
820
SiriusXM
SIRI
$10.3B
| $1.22M | ﹤0.01% |
22,391
+11,199
| +100% | +$538K |
|
821
News Corp Class B
NWS
$17.6B
| $1.22M | ﹤0.01% |
47,278
+20,115
| +74% | +$455K |
|
822
Ryman Hospitality Properties
RHP
$7.99B
| $1.18M | ﹤0.01% |
10,697
-1,582
| -13% | -$151K |
|
|
RNAM
823
DELISTED
Avidity Biosciences
RNAM
| $1.17M | ﹤0.01% |
+129,414
| New | +$865K |
|
|
WCN
824
Waste Connections
WCN
$43.7B
| $1.17M | ﹤0.01% |
7,842
-3,566
| -31% | -$490K |
|
825
TScan Therapeutics
TCRX
$59.8M
| $1.17M | ﹤0.01% |
+200,000
| New | +$916K |
|
Similar funds
Aberdeen Group's Q4 2023 Portfolio in Review
As of Q4 2023, Aberdeen Group held 995 positions worth $46.1B, up 18% from $39.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group deployed $2.24B of net new capital in Q4 2023, opening 107 new positions and adding to 596 existing holdings. Its largest new stake was Veralto: 984,184 shares worth $81M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $209M trimmed.
- Aberdeen Group's largest Q4 2023 buy was Veralto: 984,184 shares worth $81M.
- Aberdeen Group added most to NVIDIA in Q4 2023, an estimated $231M increase.
- Aberdeen Group's biggest Q4 2023 reduction was Microsoft, cutting an estimated $209M.
- Aberdeen Group fully exited VMware, Inc in Q4 2023, selling an estimated $61M.
- Aberdeen Group's ten largest holdings make up 24% of its $46.1B portfolio in Q4 2023.
- Aberdeen Group opened 107 new positions and closed 35 in Q4 2023.
- Aberdeen Group's portfolio value rose 18% quarter-over-quarter to $46.1B.
Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.